MAGELLAN HEALTH INC·4

Jan 3, 8:08 PM ET

Rubin Jonathan N 4

4 · MAGELLAN HEALTH INC · Filed Jan 3, 2018

Insider Transaction Report

Form 4
Period: 2018-01-02
Rubin Jonathan N
Chief Financial Officer
Transactions
  • Exercise of In-Money

    Ordinary Common Stock, $0.01 par value

    2018-01-02$53.72/sh+17,443$937,03843,890 total
  • Exercise of In-Money

    Stock Options (right to buy)

    2018-01-0217,44353,850 total
    Exercise: $53.72Exp: 2025-11-02Common Stock (17,443 underlying)
  • Sale

    Ordinary Common Stock, $0.01 par value

    2018-01-02$96.07/sh17,443$1,675,78226,447 total
Footnotes (5)
  • [F1]This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
  • [F2]The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $95.15 to $97.00, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
  • [F3]All of the stock options in this tranche have vested in full.
  • [F4]Of the remainder of 53,850 options in this tranche, 30,086 are currently exercisable. The remainder of 23,764 options shall vest on November 2, 2018.
  • [F5]Not applicable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION